(1)
Evaluation of Hematological Inflammatory Markers in Differentiating Benign from Malignant Endometrial Lesions in Women With Abnormal Uterine Bleeding. Ann. coll. Med. Mosul 2026, 48 (1), 100-105. https://doi.org/10.33899/acmm.v48.i1.62889.